These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2152777)

  • 41. Timolol treatment in the irritable bowel syndrome.
    Fielding JF
    Digestion; 1981; 22(3):155-8. PubMed ID: 6269935
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of cholecystokinin on colonic motility and symptoms in patients with the irritable-bowel syndrome.
    Harvey RF; Read AE
    Lancet; 1973 Jan; 1(7793):1-3. PubMed ID: 4118538
    [No Abstract]   [Full Text] [Related]  

  • 43. A randomised double-blind placebo-controlled trial of lidamidine HCL in irritable bowel syndrome.
    Awad RA; Llorens F; Camelo AL; Sánchez M
    Acta Gastroenterol Latinoam; 2000; 30(3):169-75. PubMed ID: 10975022
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of a high-fiber diet on symptoms of irritable bowel syndrome: a randomized clinical trial.
    Aller R; de Luis DA; Izaola O; la Calle F; del Olmo L; Fernandez L; Arranz T; González Hernandez JM
    Nutrition; 2004 Sep; 20(9):735-7. PubMed ID: 15325678
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Modification of visceral sensitivity and pain in irritable bowel syndrome by 5-HT3 antagonism (ondansetron).
    Goldberg PA; Kamm MA; Setti-Carraro P; van der Sijp JR; Roth C
    Digestion; 1996; 57(6):478-83. PubMed ID: 8913711
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Octylonium bromide in the treatment of the irritable bowel syndrome: a clinical-functional study.
    Baldi F; Longanesi A; Blasi A; Monello S; Cestari R; Missale G; Corazziari E; Badiali G; Marzio L; Di Felice F
    Hepatogastroenterology; 1992 Oct; 39(5):392-5. PubMed ID: 1459516
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oral domperidone: double blind comparison with placebo in irritable bowel syndrome.
    Cann PA; Read NW; Holdsworth CD
    Gut; 1983 Dec; 24(12):1135-40. PubMed ID: 6357963
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of the therapeutic effect of wheat bran, mebeverine and placebo in patients with the irritable bowel syndrome.
    Kruis W; Weinzierl M; Schüssler P; Holl J
    Digestion; 1986; 34(3):196-201. PubMed ID: 3019810
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Domperidone treatment in the irritable bowel syndrome.
    Fielding JF
    Digestion; 1982; 23(2):125-7. PubMed ID: 6284574
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of sigmoid colon distension on the rectosigmoid junction. Description of the rectosigmoid junction tightening reflex and its clinical implications.
    Shafik A; El-Sibai O
    Eur Surg Res; 2000; 32(5):310-4. PubMed ID: 11111177
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increased segmental activity and intraluminal pressures in the sigmoid colon of patients with the irritable bowel syndrome.
    Rogers J; Henry MM; Misiewicz JJ
    Gut; 1989 May; 30(5):634-41. PubMed ID: 2731756
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical and functional evaluation of the efficacy of otilonium bromide: a multicenter study in Italy.
    Baldi F; Longanesi A; Blasi A; Monello S; Cestari R; Missale G; Corazziari E; Badiali G; Pescatori M; Anastasio G
    Ital J Gastroenterol; 1991 Nov; 23(8 Suppl 1):60-3. PubMed ID: 1756285
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Manometric effects of pinaverium bromide in irritable bowel syndrome].
    Soifer L; Varela E; Olmos J
    Acta Gastroenterol Latinoam; 1992; 22(1):37-43. PubMed ID: 1295286
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Irritable bowel syndrome: assessment of psychological disturbance and its influence on the response to fibre supplementation.
    Fowlie S; Eastwood MA; Prescott R
    J Psychosom Res; 1992 Feb; 36(2):175-80. PubMed ID: 1313875
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of the dietary fiber glucomannan on chronic constipation in neurologically impaired children.
    Staiano A; Simeone D; Del Giudice E; Miele E; Tozzi A; Toraldo C
    J Pediatr; 2000 Jan; 136(1):41-5. PubMed ID: 10636972
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A comparison of mebeverine with high-fibre dietary advice and mebeverine plus ispaghula in the treatment of irritable bowel syndrome: an open, prospectively randomised, parallel group study.
    Chapman ND; Grillage MG; Mazumder R; Atkinson SN
    Br J Clin Pract; 1990 Nov; 44(11):461-6. PubMed ID: 2177997
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Irritable bowel syndrome and dietary fiber.
    Achord JL
    J Am Diet Assoc; 1979 Oct; 75(4):452-3. PubMed ID: 113444
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dietary fibre and the irritable bowel syndrome.
    Fielding JF; Melvin K
    J Hum Nutr; 1979 Aug; 33(4):243-7. PubMed ID: 479584
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Treatment of irritable bowel with dietary fiber. A controlled clinical study].
    Rasmussen SN; Bondesen S; Edmund C; Frandsen I; Andersen I; Kempel K; Nielsen K
    Ugeskr Laeger; 1982 Aug; 144(33):2415-7. PubMed ID: 6294938
    [No Abstract]   [Full Text] [Related]  

  • 60. Reduction of post-prandial motility by pinaverium bromide a calcium channel blocker acting selectively on the gastrointestinal tract in patients with irritable bowel syndrome.
    Awad RA; Cordova VH; Dibildox M; Santiago R; Camacho S
    Acta Gastroenterol Latinoam; 1997; 27(4):247-51. PubMed ID: 9401097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.